• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Senseonics Holdings Inc.

    6/2/25 4:05:26 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    SD 1 tm2516634d1_sd.htm FORM SD

     

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION 

    Washington, D.C. 20549

     

    FORM SD

     

    SPECIALIZED DISCLOSURE REPORT

     

    SENSEONICS HOLDINGS, INC.

    (Exact name of the registrant as specified in its charter)

     

    Delaware 001-37717 47-1210911
    (State or other jurisdiction of (Commission (IRS Employer
    incorporation or organization) File Number) Identification No)

     

    20451 Seneca Meadows Parkway 

    Germantown, MD 20876-7005 

    (301) 515-7260 

    (Address of principal executive offices and Zip Code)

     

     

     

    Rick Sullivan

    Chief Financial Officer

    (301) 515-7260

    (Name and telephone number, including area code, of the 

    person to contact in connection with this report.)

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

     

      x

    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

      ¨ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _______.

     

     

     

     

     

     

    Section 1 – Conflict Minerals Disclosure

     

    Item 1.01 Conflict Minerals Disclosure and Report

     

    A copy of the Conflict Minerals Report of Senseonics Holdings, Inc. (the “Company”) is attached as Exhibit 1.01 and is available at http://www.senseonics.com/investor-relations/corporate-governance/governance-documents. The Company has also adopted a policy with respect to its sourcing of conflict minerals. The full text of the Company’s Conflict Minerals Policy is available on the Company’s website at http://www.senseonics.com/investor-relations/corporate-governance/governance-documents.

     

    The information contained on, or that can be accessed through, the Company’s website is not part of this Form SD and is not deemed incorporated by reference into this Form SD.

     

    Item 1.02 Exhibit

     

    The Company has filed, as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.

     

    Section 2– Resource Extraction Issuer Disclosure

     

    Item 2.01 Resource Extraction Issuer Disclosure and Report

     

    Not applicable.

     

    Section 3 – Exhibits

     

    Item 3.01 Exhibits

     

    The following exhibit is filed as part of this report:

     

    Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

     

      SENSEONICS HOLDINGS, INC.
         
      By: /s/ Rick Sullivan
      Name: Rick Sullivan
      Title: Chief Financial Officer

     

    Dated: June 2, 2025

     

     

     

    Get the next $SENS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    6/2/2025$1.10Buy
    H.C. Wainwright
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Financials

    Live finance-specific insights

    See more
    • Senseonics Holdings, Inc. Reports First Quarter Financial Results

      Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

      5/8/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

      GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Management will hold a conference call to review the Company's first quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigat

      4/29/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients GERMANTOWN, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the fourth quarter ended December 31, 2024. Recent Highlights & Accomplishments: Eversense® 365 approved and launched in the U.S. during 2024 as an integrated contin

      3/3/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    SEC Filings

    See more
    • SEC Form SD filed by Senseonics Holdings Inc.

      SD - Senseonics Holdings, Inc. (0001616543) (Filer)

      6/2/25 4:05:26 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form D filed by Senseonics Holdings Inc.

      D - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/29/25 4:24:35 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Senseonics Holdings, Inc. (0001616543) (Filer)

      5/21/25 4:02:02 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

      GERMANTOWN, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it will host an in-person and virtual analyst event in conjunction with the American Diabetes Association 85th Scientific Sessions (ADA 2025), on Saturday, June 21, 2025 at 8:00am CT at the Marriot Marquis Chicago. To register, click here. The event will feature company management who will discuss the next-generation Eversense® 365 Continuous Glucose Monitoring (CGM) system, approved by the U.S. Food and Drug Admini

      6/4/25 4:05:00 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

      Public offering results in gross proceeds of $57.5 millionPrivate placement results in gross proceeds of approximately $20.3 million GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the closing of its previously announced underwritten public offering of a total of 115,000,000 shares of its common stock, which included the exercise in full by the underwriters of their option to purchase up to an additional 15,000,000 shares of common stock, at a public offering price

      5/21/25 5:06:26 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

      GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the pricing of an underwritten public offering of 100,000,000 shares of common stock at a price to the public of $0.50 per share of common stock. The gross proceeds to Senseonics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $50,000,000. In addition, Senseonics granted the underwriters a 30-day option to purchase up to an additional 15,000,

      5/15/25 11:12:42 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4)

      4/A - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/20/24 5:37:53 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/16/24 4:21:25 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      12/12/24 7:04:14 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      2/13/24 5:13:59 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

      SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

      7/7/23 4:35:55 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Senseonics Holdings Inc.

      SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

      4/10/23 5:10:45 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Hansen Brian B was granted 842,084 shares (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      5/29/25 4:15:09 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Prince Douglas S was granted 111,386 shares, increasing direct ownership by 12% to 1,070,538 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      5/28/25 4:32:47 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Director Larkin Sharon was granted 111,386 shares, increasing direct ownership by 21% to 640,206 units (SEC Form 4)

      4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

      5/28/25 4:31:28 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • H.C. Wainwright resumed coverage on Senseonics with a new price target

      H.C. Wainwright resumed coverage of Senseonics with a rating of Buy and set a new price target of $1.10

      6/2/25 8:54:33 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Mizuho initiated coverage on Senseonics with a new price target

      Mizuho initiated coverage of Senseonics with a rating of Outperform and set a new price target of $2.00

      4/10/25 12:43:40 PM ET
      $SENS
      Industrial Machinery/Components
      Industrials
    • Jefferies initiated coverage on Senseonics with a new price target

      Jefferies initiated coverage of Senseonics with a rating of Underperform and set a new price target of $0.50

      7/19/23 7:24:20 AM ET
      $SENS
      Industrial Machinery/Components
      Industrials